BLUE Market Cap History
Below is a table of the BLUE market cap history going back to 6/19/2013:

Date BLUE Market Cap
6/19/2013588.51M
7/29/2013731.80M
10/31/2013505.33M
2/24/2014586.11M
5/8/2014433.62M
7/29/2014968.54M
11/6/20141.20B
2/18/20152.99B
4/28/20154.36B
7/31/20156.01B
10/30/20152.83B
2/18/20161.92B
4/30/20161.64B
7/29/20162.13B
10/28/20161.86B
2/17/20173.15B
4/28/20173.64B
7/28/20174.41B
10/27/20176.45B
2/16/201810.66B
4/27/20188.71B
7/27/20188.80B
10/26/20186.11B
2/15/20197.53B
4/26/20197.88B
7/25/20197.74B
10/25/20194.55B
2/13/20204.98B
5/5/20203.13B
7/31/20204.02B
10/30/20203.43B
2/18/20211.81B
4/30/20212.02B
8/3/20211.70B
11/1/20211.70B

Also see: BLUE Shares Outstanding History
and BLUE YTD Return
BLUE Historical Market Cap:
+13.49% CAGR
BLUE Historical Market Cap: +13.49% CAGR

Mouse over chart for data details
6/19/2013 ...11/1/2021
bluebird bio is a biotechnology company focused on researching, developing, and commercializing potentially transformative gene therapies for severe genetic diseases and cancer. Co.'s programs in severe genetic disease include betibeglogene autotemcel; LentiGlobin gene therapy for sickle cell disease; and elivaldogene autotemcel. Co.'s programs in oncology are focused on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor T cell therapies. Idecabtagene vicleucel, or ide-cel, and bb21217 are CAR-T cell product candidates for the treatment of multiple myeloma and partnered under Co.'s collaboration arrangement with Bristol-Myers Squibb. We show 35 historical shares outstanding datapoints in our BLUE shares outstanding history coverage, used to compute BLUE market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BLUE market cap history over the course of time is important for investors interested in comparing BLUE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BLUE versus a peer is one thing; comparing BLUE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BLUE can fluctuate over the course of history. With this page we aim to empower investors researching BLUE by allowing them to research the BLUE market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree BLUE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
bluebird bio (BLUE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

BMEA Market Cap History
BMRA Market Cap History
BMRN Market Cap History
BMY Market Cap History
BNGO Market Cap History
BNTC Market Cap History
BOLD Market Cap History
BOLT Market Cap History
BPMC Market Cap History
BPTH Market Cap History
More Healthcare companies »

 

BLUE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.